From the Q: gross profit $154,193 see below
RESULTS OF OPERATIONS FOR THE SIX MONTHS ENDED JUNE 30, 2019 COMPARED TO THE SIX MONTHS ENDED JUNE 30, 2018
Revenue
We recognized net revenue of $443,193 and $11,517 during the six-month periods ended June 30, 2019 and 2018, respectively. Revenues were from the sales of our nutrition supplement in the six months ended June 30, 2018 and from both supplements sales and telemedicine for the six months ended June 30, 2019. The increase in revenue is attributable to the acquisition of the CareClix™ software and start-up of the new business of CareClix, Inc. in April 2019.
Cost of Revenue
We recognized cost of revenues of $288,563 and $4,450 during the six-month periods ended June 30, 2019 and 2018, respectively. Cost of revenue consisted of product costs and fulfillment fees for sales through the Internet for nutrition supplement sales and fees to an unrelated medical professional corporation for providing medical doctors for telemedicine consulting services.
Gross Profit / (Loss)
Gross profit was $154,630 and $7,067 for the six month periods ended June 30, 2019 and 2018, respectively.
